Remed Co.Ltd (302550) - Total Liabilities

Latest as of March 2026: ₩15.50 Billion KRW ≈ $10.51 Million USD

Based on the latest financial reports, Remed Co.Ltd (302550) has total liabilities worth ₩15.50 Billion KRW (≈ $10.51 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 302550 net assets growth trend to track the company's year-over-year net asset growth rate.

Remed Co.Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Remed Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See Remed Co.Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Remed Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Remed Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
2S Metal Public Company Limited BK:2S	Thailand	฿342.86 Million
Cross Timbers Royalty Trust NYSE:CRT	USA	$1.51 Million
G5 Entertainment publ AB ST:G5EN	Sweden	Skr86.95 Million
Kanpur Plastipack Limited NSE:KANPRPLA	India	Rs2.01 Billion
Mobiis Co. Ltd KQ:250060	Korea	₩6.34 Billion
Orexo AB ST:ORX	Sweden	Skr245.70 Million
MFO SA WAR:MFO	Poland	zł309.50 Million
Choheung KO:002600	Korea	₩283.32 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Remed Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Remed Co.Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Remed Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Remed Co.Ltd (2017–2025)

The table below shows the annual total liabilities of Remed Co.Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩14.45 Billion ≈ $9.79 Million	-23.22%
2024-12-31	₩18.81 Billion ≈ $12.75 Million	-22.47%
2023-12-31	₩24.27 Billion ≈ $16.44 Million	-49.66%
2022-12-31	₩48.21 Billion ≈ $32.67 Million	-5.66%
2021-12-31	₩51.10 Billion ≈ $34.63 Million	+4.97%
2020-12-31	₩48.68 Billion ≈ $32.99 Million	+371.60%
2019-12-31	₩10.32 Billion ≈ $7.00 Million	-2.32%
2018-12-31	₩10.57 Billion ≈ $7.16 Million	+25.67%
2017-12-31	₩8.41 Billion ≈ $5.70 Million	--

About Remed Co.Ltd

KQ:302550 Korea Medical Devices

Market Cap

$54.78 Million

₩80.83 Billion KRW

Market Cap Rank

#21497 Global

#1239 in Korea

Share Price

₩2670.00

Change (1 day)

+2.50%

52-Week Range

₩2485.00 - ₩3985.00

All Time High

₩4180.00